157 related articles for article (PubMed ID: 26939070)
1. Metastases and Colon Cancer Tumor Growth Display Divergent Responses to Modulation of Canonical WNT Signaling.
Seth C; Ruiz i Altaba A
PLoS One; 2016; 11(3):e0150697. PubMed ID: 26939070
[TBL] [Abstract][Full Text] [Related]
2. Long-Lasting WNT-TCF Response Blocking and Epigenetic Modifying Activities of Withanolide F in Human Cancer Cells.
Seth C; Mas C; Conod A; Mueller J; Siems K; Kuciak M; Borges I; Ruiz i Altaba A
PLoS One; 2016; 11(12):e0168170. PubMed ID: 27973612
[TBL] [Abstract][Full Text] [Related]
3. The protein secretion modulator TMED9 drives CNIH4/TGFα/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases.
Mishra S; Bernal C; Silvano M; Anand S; Ruiz I Altaba A
Oncogene; 2019 Jul; 38(29):5817-5837. PubMed ID: 31253868
[TBL] [Abstract][Full Text] [Related]
4. A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12.
Duquet A; Melotti A; Mishra S; Malerba M; Seth C; Conod A; Ruiz i Altaba A
EMBO Mol Med; 2014 Jul; 6(7):882-901. PubMed ID: 24920608
[TBL] [Abstract][Full Text] [Related]
5. Loss of WNT-TCF addiction and enhancement of HH-GLI1 signalling define the metastatic transition of human colon carcinomas.
Varnat F; Siegl-Cachedenier I; Malerba M; Gervaz P; Ruiz i Altaba A
EMBO Mol Med; 2010 Nov; 2(11):440-57. PubMed ID: 20941789
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer.
Larriba MJ; Ordóñez-Morán P; Chicote I; Martín-Fernández G; Puig I; Muñoz A; Pálmer HG
PLoS One; 2011; 6(8):e23524. PubMed ID: 21858154
[TBL] [Abstract][Full Text] [Related]
7. A Wnt kinase network alters nuclear localization of TCF-1 in colon cancer.
Najdi R; Syed A; Arce L; Theisen H; Ting JH; Atcha F; Nguyen AV; Martinez M; Holcombe RF; Edwards RA; Marsh JL; Waterman ML
Oncogene; 2009 Nov; 28(47):4133-46. PubMed ID: 19749792
[TBL] [Abstract][Full Text] [Related]
8. The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer.
Melotti A; Mas C; Kuciak M; Lorente-Trigos A; Borges I; Ruiz i Altaba A
EMBO Mol Med; 2014 Oct; 6(10):1263-78. PubMed ID: 25143352
[TBL] [Abstract][Full Text] [Related]
9. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.
Nguyen DX; Chiang AC; Zhang XH; Kim JY; Kris MG; Ladanyi M; Gerald WL; Massagué J
Cell; 2009 Jul; 138(1):51-62. PubMed ID: 19576624
[TBL] [Abstract][Full Text] [Related]
10. Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation.
Feng Y; Bommer GT; Zhai Y; Akyol A; Hinoi T; Winer I; Lin HV; Cadigan KM; Cho KR; Fearon ER
Cancer Res; 2007 Jan; 67(2):482-91. PubMed ID: 17234755
[TBL] [Abstract][Full Text] [Related]
11. Post-translational glycoprotein modifications regulate colon cancer stem cells and colon adenoma progression in Apc(min/+) mice through altered Wnt receptor signaling.
Guo H; Nagy T; Pierce M
J Biol Chem; 2014 Nov; 289(45):31534-49. PubMed ID: 25274627
[TBL] [Abstract][Full Text] [Related]
12. Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells.
Flores-Hernández E; Velázquez DM; Castañeda-Patlán MC; Fuentes-García G; Fonseca-Camarillo G; Yamamoto-Furusho JK; Romero-Avila MT; García-Sáinz JA; Robles-Flores M
Cell Signal; 2020 Aug; 72():109636. PubMed ID: 32283254
[TBL] [Abstract][Full Text] [Related]
13. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
14. Esculetin suppresses proliferation of human colon cancer cells by directly targeting β-catenin.
Lee SY; Lim TG; Chen H; Jung SK; Lee HJ; Lee MH; Kim DJ; Shin A; Lee KW; Bode AM; Surh YJ; Dong Z
Cancer Prev Res (Phila); 2013 Dec; 6(12):1356-64. PubMed ID: 24104353
[TBL] [Abstract][Full Text] [Related]
15. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
[TBL] [Abstract][Full Text] [Related]
16. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
[TBL] [Abstract][Full Text] [Related]
17. The Yin-Yang of TCF/beta-catenin signaling.
Barker N; Morin PJ; Clevers H
Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
[TBL] [Abstract][Full Text] [Related]
18. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
19. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
20. Tumor Suppressive Role of ARHGAP17 in Colon Cancer Through Wnt/β-Catenin Signaling.
Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
Cell Physiol Biochem; 2018; 46(5):2138-2148. PubMed ID: 29730655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
